期刊文献+

胃癌患者血清可溶性IL-2受体、T细胞亚群及NK细胞的临床观察 被引量:7

The clinical investigation of serum soluble interleukin-2 receptor,T cell subsets and natural killer cells in patients with gastric cancer
下载PDF
导出
摘要 目的 较全面地观察胃癌患者的细胞免疫功能 ,为胃癌的预测、诊断、病情估计及免疫治疗提供依据。方法 应用酶联免疫双抗夹心法 (ELISA)及碱性磷酸酶抗碱性磷酸酶 (APAAP)桥联酶标法 ,检测 3 4例胃癌患者与对照者血清可溶性白细胞介素 -2受体 (sIL -2R)、T淋巴细胞亚群及自然杀伤 (NK)细胞。结果 胃癌患者sIL-2R水平明显高于对照组 (P <0 0 1) ,Ⅲ、Ⅳ期高于Ⅰ、Ⅱ期 (P <0 0 1) ;CD4、CD8、CD4/CD8低于对照组 (P <0 .0 5 ) ,Ⅲ、Ⅳ期低于Ⅰ、Ⅱ期 (P<0 0 5 ) ;NK细胞百分比显著低于对照组 (P <0 0 1) ,Ⅲ、Ⅳ期明显低于Ⅰ、Ⅱ期 (P <0 0 1)。结论 多指标检测表明胃癌病人细胞免疫功能明显下降。推测细胞免疫功能下降、免疫监视功能低下可能是患胃癌的重要原因 ;检测细胞免疫功能对胃癌的预测、诊断、病情估计及免疫治疗的选择均有重要价值。 Aim Completely investigating the cellular immunological function in order to provide the proof about the prediction,diagnosis,evaluation and immunotherapy of gastric cancer(GC). Methods Sandwiched enzymelinked immunosorbent assay (ELISA) and alkaline phosphatase antialkaline phosphatase (APAAP) were used to detect the serum sIL-2R,T-lymphocyte subsets and natural killer (NK)cells in 34 GC cases and in the control group. Restults The serum sIL-2R level in GC was obviously higher than that in the control group (p<0.01),that in Stage Ⅲ and Ⅳ was higher than that in Stage Ⅰ and Ⅱ (P<0.01);CD + 4,CD + 8, and CD +/CD + 8 were lower than those in the control group (P<0.01),those in stage Ⅲ and Ⅳ were lower than those in Stage Ⅰand Ⅱ (P<0.05);the percentage of NK cells was significantly lower than that in the control group (P<0.01),that in Stage Ⅲ and Ⅳ was lower than that in Stage Ⅰ and Ⅱ(P<0.01).Conclusions The results of this study suggested that the cellular immunological function in patients with GC obviously decreased.The decrease of cellular immunity and immunosurveillance might be the important cause of GC;It is of great value for the prediction,diagnosis,evaluation and immunotherapy selection to detect the celluar immunological function.
出处 《胃肠病学和肝病学杂志》 CAS 1999年第4期277-278,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 胃癌 细胞免疫 SIL-2R T细胞亚群 NK细胞 Gastric cancer Cellular immunological function sIL-2R T-lymphocyte subset NK cell
  • 相关文献

参考文献1

二级参考文献9

  • 1Robin LA, Neson DL The soluble interleukin-2 receptor:biology, function, and clinical application. Ann Inter Med,1990,113:619-627.
  • 2Roch CS Lowry SF.Current research review:tumor necrosis factor-α J Surg,1991,5:434-439.
  • 3Lissoni P. Barni S, Rovelli F, et al. The biological significance of soluble interleukin-2 receptor in solid tumors Eur J Cancer,1990,26:33 -36.
  • 4Lai KN, Ho S, Leung JCH, et al. Soluble interleukin-2 receptor in patient with nosopharryngeal carcinoma Cancer,1991,67:2180-2185.
  • 5Tisi E, Lissoni P. Angeli F, et al. Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma. Cancer,1992,69:2458-2462.
  • 6Marion P, Gugno M, Preationi A, et al. Increased levels of sIL-2R in serum of patients with lung cancer. Br J Cancer, 1990,61:434-435.
  • 7Spatafora M. Antitumor activity of mononuclear progocytis role of tumour necrosis factor alpha. Respiration 1992,59 (suppl):47.
  • 8Naylor MS, Stamp GWH, Faulkes WD, et al. Tumor necrosis factor and its receptor in human ovarian cancer:potential role in disease progression. J Clin Invest.1993,91:2194-2206.
  • 9Nakazaki H. Preoperative and postoperative cytokines in patients with cancer. Cancer, 1992,70:709-713.

共引文献10

同被引文献42

  • 1王亚娟,王爱芬.肺癌患者外周血T淋巴细胞亚群检测的临床研究[J].肿瘤防治杂志,2004,11(7):726-727. 被引量:23
  • 2王玉芬,韩双红,曲树明,赵泰.蜈蚣延缓衰老作用的研究[J].中国中药杂志,1994,19(11):685-687. 被引量:19
  • 3李小荣,杨连粤,贺志军.大肠癌患者手术前后细胞免疫变化的初步研究[J].中国现代医学杂志,1996,6(4):15-16. 被引量:1
  • 4张华荣,姜国辉.党参药理与临床研究进展[J].中医药信息,1996,13(5):17-21. 被引量:39
  • 5Neglia F, Orengo AM, Cilli Met al. DNA vaccination against the ovari- an cancinoma - associated antigen folate receptor alpha (Fralpha) inducescytotoxic T lymphocyte and antibody responses in mice. Cancer Gene Ther, 1999, 6:349.
  • 6Vanderkwaak TJ, Alvarez R. Immune directed therapy for ovarian carcinoma. Curr Opin Obstet Gynecol , 1999, 11 : 29.
  • 7Fernadez Cruz. Elimination of syngeneie sarcomas in rats by a subset of T lymphocytes. JExp Med, 1980, 152:82.
  • 8Katsumoto Y, Monden T , Takoda T et al. Analysis of cytotoxic active ofthe CD4 + T lymphocytes generated by local immunotherapy. Br JCancer, 1996, 73:110.
  • 9Schroder W , Vering A, Stegmuller M et al. Lymphocyte subsetsin patients with Ovarian and breast cancer. Eur J Gynaecol Oneol, 1997, 18 (6) : 474.
  • 10Nelson BH. The impact of T - cell immunity on ovarian cancer outcomes. Immunol Rev, 2008, 222 ( 1 ) : 101.

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部